
Muhammad Umair Mushtaq: Outcomes of Allo-HCT in MF Patients Aged 65 Years and Above
Muhammad Umair Mushtaq, Associate Professor of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center, shared a post on X about a paper he co-authored with colleagues, published in Clinical Lymphoma Myeloma and Leukemia:
“Outcomes of Allo-HCT in MF patients aged >65 years.”
Title: Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 65 Years and Above with Myelofibrosis
Journal: Clinical Lymphoma Myeloma and Leukemia
Authors: Moazzam Shahzad, Muhammad Kashif Amin, Sohaib Irfan, Rania Ahsan, Hana Qasim, Muhammad Jawad Javed, Matthew McGuirk, Sibgha Gull Chaudhary, Iqra Anwar, Abdulraheem Yacoub, Anurag K. Singh, Mehdi Hamadani, Joseph P. Mcguirk, Muhammad Umair Mushtaq
More posts featuring Muhammad Umair Mushtaq on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023